7.02
+0.52
+(8.06%)
As of 10:20:06 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,521
4,521
4,348
3,084
852
Cost of Revenue
1,552
1,552
1,656
1,150
303
Gross Profit
2,969
2,969
2,692
1,934
549
Operating Expense
61,778
61,778
47,794
34,433
26,791
Operating Income
-58,809
-58,809
-45,102
-32,499
-26,242
Net Non Operating Interest Income Expense
599
599
1,370
-441
-1,597
Other Income Expense
1,778
1,778
-925
2,884
3,200
Pretax Income
-56,432
-56,432
-44,657
-30,056
-24,639
Tax Provision
2,804
2,804
-1,445
1,169
2,980
Net Income Common Stockholders
-59,236
-59,236
-43,212
-31,225
-27,619
Diluted NI Available to Com Stockholders
-59,236
-59,236
-43,212
-31,225
-27,619
Basic EPS
-1.73
-1.81
-1.54
-1.21
-1.16
Diluted EPS
-1.73
-1.81
-1.54
-1.21
-1.16
Basic Average Shares
30,624.86
32,743.61
27,968.14
25,827.13
23,809.48
Diluted Average Shares
30,624.86
32,743.61
27,968.14
25,827.13
23,809.48
Total Operating Income as Reported
-58,809
-58,809
-45,102
-32,499
-26,242
Rent Expense Supplemental
639
639
317
440
247
Total Expenses
63,330
63,330
49,450
35,583
27,094
Net Income from Continuing & Discontinued Operation
-59,236
-59,236
-43,212
-31,225
-27,619
Normalized Income
-60,569.50
-60,569.50
-42,316.93
-33,996.81
-30,431.80
Interest Income
2,502
2,502
2,571
372
1
Interest Expense
886
886
217
237
386
Net Interest Income
599
599
1,370
-441
-1,597
EBIT
-55,546
-55,546
-44,440
-29,819
-24,253
EBITDA
-52,828
-52,828
-42,080
-27,887
-22,591
Reconciled Cost of Revenue
118
118
338
132
303
Reconciled Depreciation
2,718
2,718
2,360
1,932
1,662
Net Income from Continuing Operation Net Minority Interest
-59,236
-59,236
-43,212
-31,225
-27,619
Total Unusual Items Excluding Goodwill
1,778
1,778
-925
2,884
3,200
Total Unusual Items
1,778
1,778
-925
2,884
3,200
Normalized EBITDA
-54,606
-54,606
-41,155
-30,771
-25,791
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
444.50
444.50
-29.93
112.19
387.20
12/31/2021 - 4/28/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MMSI Merit Medical Systems, Inc.
104.91
-1.99%
TFX Teleflex Incorporated
140.76
-0.44%
KMTS Kestra Medical Technologies, Ltd. Common Stock
24.28
-5.54%
AZTA Azenta, Inc.
32.18
-9.12%
ANGO AngioDynamics, Inc.
9.79
-9.85%
NVST Envista Holdings Corporation
16.08
-8.17%
GXI.VI Gerresheimer AG
65.60
-3.81%
ADDV-A.ST ADDvise Group AB (publ)
4.4200
-3.70%
FEMY Femasys Inc.
1.2500
-3.10%
MHUA Meihua International Medical Technologies Co., Ltd.
0.3206
-2.88%